By Brian Shilhavy | Health Impact News | June 9, 2021 Big Pharma has been trying to create a blockbuster drug for the very lucrative Alzheimer’s Disease for more than a decade. But they have repeatedly failed, mainly because they start with the wrong presuppositions on the cause of Alzheimer’s, basing it on “genetics” instead […]
Source